Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Fri, 13th Aug 2021 14:45

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Insig AI PLC - venture capital firm formerly known as Catena Group PLC - Matthew Farnum-Schneider resigns as executive chair, leaving after a short handover period, having served for two years. Richard Bernstein, "a long-term supporter and shareholder", is named interim non-executive chair until a permanent independent non-executive chair can be found. Bernstein, a 12.6% shareholder in Insig AI, was investment manager of AIM-listed Crystal Amber Fund Ltd.

----------

Palace Capital PLC - investor in regional UK commercial real estate - Stephen Silvester steps down as chief financial officer, leaving the board on October 29 after six years with Palace Capital. Head of Finance & Operations Matthew Simpson is promoted to finance director designate.

----------

US Solar Fund PLC - owns and operates solar power assets in North America - Notes that New Energy Solar Manager, the fund's manager, has promoted Liam Thomas to chief executive officer from chief investment officer. Thomas joined NESM in 2016 and has 17 years experience in the renewable energy, infrastructure, and agribusiness sectors, US Solar Fund says. Thomas replaces John Martin, who is leaving on September 30 to join renewable energy developer Windlab Pty Ltd.

----------

City Of London Investment Trust PLC - Hires Ominder Dhillon as a non-executive director, starting September 1. Dhillon was global head of Institutional Distribution at asset manager M&G PLC until the start of 2020. Prior M&G, he was head of Distribution at Impax Asset Management Group PLC.

----------

Keywords Studios PLC - Dublin-based technical services for video game developers - Hires Marion Sears and Neil Thompson as independent non-executive directors, starting immediately. Sears was a City analyst and investment banker. She currently is a non-executive director of retailer Dunelm Group PLC and senior independent director of Fidelity European Trust PLC and of Aberdeen New Dawn Investment Trust PLC. Thompson held senior positions at software firm Microsoft Corp and was part of the management team that launched Xbox into Europe, Keywords notes.

----------

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Hires Julie Krop as chief medical officer, joining from Nasdaq-listed Freeline Therapeutics Holdings PLC, where she held the same position.

----------

Prospex Energy PLC - investor in onshore and shallow offshore European gas and power projects - Receives letter from group of shareholders requisitioning a general meeting to remove existing and proposed directors and appoint new ones. Prospex says the documentation received doesn't form a valid request. Therefore, it won't call the meeting. However, the board has spoken to the shareholders and invited them to submit a valid request. Shareholders last month rejected the re-appointment of James Smith as a director, and the board currently has only three members.

----------

Trinity Exploration & Production PLC - oil assets in Trinidad and Tobago - Confirms Nicholas Clayton as permanent non-executive chair. Clayton had taken on the role on an interim basis following the death earlier this month of Bruce Dingwall, who had been executive chair. Managing Director Jeremy Bridglalsingh is promoted to CEO.

----------

Block Energy PLC - oil and gas development and production company focused on Georgia - Hires Jeremy Asher as non-executive director, effective immediately. Asher is chair & CEO of AIM-listed Tower Resources PLC. Block Energy shareholders at a general meeting on Wednesday had rejected proposals by Forest Nominees Ltd, acting on behalf of GP Jersey Ltd, to remove Chair Philip Dimmock and replace him with Charles Valceschini. Over 60% of votes were against both resolutions.

----------

Abcam PLC - Cambridge, England-based life science research tools - Hires Sally Crawford as non-executive director, starting immediately. Crawford was chief operating officer of US managed care firm Healthsource Inc and now is a health care consultant, based in New Hampshire.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
31 Jul 2018 15:42

Berenberg changes mind on Abcam, reinstating 'buy' rating

(Sharecast News) - Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from 'Hold' to 'Buy' after having downgraded shares of the antibodies supplier just three months ago.

Read more
31 Jul 2018 13:26

Tuesday broker round-up

(Sharecast News) - Abcam: Berenberg upgrades to buy with a target price of 1,640p.

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
9 May 2018 16:16

UPDATE: Horizon Discovery Outlook Strong In Face Of Abcam Pull-Out

LONDON (Alliance News) - Horizon Discovery Group PLC on Wednesday noted Abcam PLC's statement earlier in the day it will not be making an offer for Horizon.The gene modulation company a

Read more
9 May 2018 12:33

Abcam Decides Not To Make An Offer For Horizon Discovery Group

LONDON (Alliance News) - Abcam PLC on Wednesday said it has ended plans to make an offer for Horizon Discovery Group PLC following the latter's release of its annual results and a management a

Read more
2 May 2018 18:25

Horizon Discovery Confirms Rejected "Unsolicited" Abcam Proposal

LONDON (Alliance News) - Genomics firm Horizon Discovery Group PLC on Wednesday confirmed it had rejected an unsolicited and "highly conditional" proposal from Abcam PLC.The life

Read more
2 May 2018 16:41

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.The life science e-commerce company said it a for

Read more
15 Mar 2018 09:53

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE WITH

Read more
7 Mar 2018 15:23

FDA head Gottlieb criticizes industry for "Kabuki drug-pricing"

WASHINGTON, March 7 (Reuters) - U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health a

Read more
11 Jan 2017 09:36

BROKER RATINGS SUMMARY: Morgan Stanley Upgrades BT To Overweight

Read more
10 Jan 2017 10:30

Abcam's revenue to be ahead of expectations

(ShareCast News) - Cambridge-based life science company Abcam said it anticipates revenue will continue to grow in the second half of the year, ahead of expectations. The AIM-listed company company expects revenue to grow 10% on a constant currency basis and 30% on a reported basis as it is on track

Read more
24 Oct 2016 10:28

Abcam commits to massive new Cambridge headquarters

(ShareCast News) - Life science research tools supplier Abcam announced on Monday that it has committed to the lease of a new facility for its global headquarters at the Biomedical Campus in Cambridge, subject to the grant of full planning approval. The AIM-traded firm said the purpose-built facilit

Read more
28 Sep 2016 11:29

DIRECTOR DEALINGS: Abcam COO Donates 62,000 Shares to Charity

Read more
12 Sep 2016 10:40

Abcam earnings dip slightly in year of investment

(ShareCast News) - Life science research tool supplier Abcam announced its preliminary results for the year to 30 June on Monday, with catalogue revenue increasing by 17.4% on a reported basis to £159.0m. The AIM-traded firm said at constant exchange rates the increase was 14.4%. Total revenue incr

Read more
2 Sep 2016 10:21

Abcam to place shares on AIM to pay vendors following acquisition

(ShareCast News) - Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market. The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.